{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T08:20:19Z","timestamp":1781252419814,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vaccine development for <jats:italic>Plasmodium vivax<\/jats:italic>, an important human relapsing malaria, is lagging behind. In the case of the most deadly human malaria <jats:italic>P. falciparum<\/jats:italic>, unprecedented high levels of protection have been obtained by immunization with live sporozoites under accompanying chemoprophylaxis, which prevents the onset of blood-stage malaria. Such an approach has not been fully evaluated for relapsing malaria. Here, in the <jats:italic>P. cynomolgi<\/jats:italic>-rhesus macaque model for relapsing malaria, we employ the parasites\u2019 natural relapsing phenotype to self-boost the immune response against liver-stage parasites, following a single-shot high-dose live sporozoite vaccination. This approach resulted in sterile protection against homologous sporozoite challenge in three out of four animals in the group that was also exposed for several days to blood stages during primary infection and relapses. One out of four animals in the group that received continuous chemoprophylaxis to abort blood-stage exposure was also protected from sporozoite challenge. Although obtained in a small number of animals as part of a Proof-of-Concept study, these results suggest that limited blood-stage parasite exposure may augment protection in this model. We anticipate our data are a starting point for further research into correlates of protection and extrapolation of the single-shot approach to develop efficacious malaria vaccines against relapsing human malaria.<\/jats:p>","DOI":"10.1038\/s41541-022-00555-0","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T18:08:36Z","timestamp":1666894116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sterile protection against relapsing malaria with a single-shot vaccine"],"prefix":"10.1038","volume":"7","author":[{"given":"Erica M.","family":"Pasini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9403-0515","authenticated-orcid":false,"given":"Annemarie Voorberg","family":"van der Wel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Heijmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onny","family":"Klop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Zeeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Oostermeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivonne","family":"Nieuwenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Rodriguez","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Onur","family":"van der Werff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam O.","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A. W.","family":"Verreck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5412-6958","authenticated-orcid":false,"given":"Edmond J.","family":"Remarque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6808-1204","authenticated-orcid":false,"given":"Bart W.","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-1734","authenticated-orcid":false,"given":"Clemens H. M.","family":"Kocken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"555_CR1","unstructured":"Programme, G. M. World Malaria Report. (WHO, Geneva, 2019)."},{"key":"555_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fmicb.2015.00145","volume":"6","author":"C Joyner","year":"2015","unstructured":"Joyner, C., Barnwell, J. W. & Galinski, M. R. No more monkeying around: primate malaria model systems are key to understanding Plasmodium vivax liver-stage biology, hypnozoites, and relapses. Front. Microbiol. 6, 145 (2015).","journal-title":"Front. Microbiol."},{"key":"555_CR3","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1056\/NEJMoa0805832","volume":"361","author":"M Roestenberg","year":"2009","unstructured":"Roestenberg, M. et al. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 361, 468\u2013477 (2009).","journal-title":"N. Engl. J. Med."},{"key":"555_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-6-161","volume":"6","author":"CJ Sutherland","year":"2007","unstructured":"Sutherland, C. J., Drakeley, C. J. & Schellenberg, D. How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions. Malar. J. 6, 161 (2007).","journal-title":"Malar. J."},{"key":"555_CR5","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1126\/science.1241800","volume":"341","author":"RA Seder","year":"2013","unstructured":"Seder, R. A. et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341, 1359\u20131365 (2013).","journal-title":"Science"},{"key":"555_CR6","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.1073\/pnas.1220360110","volume":"110","author":"EM Bijker","year":"2013","unstructured":"Bijker, E. M. et al. Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Proc. Natl Acad. Sci. USA 110, 7862\u20137867 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"555_CR7","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/infdis\/jiu293","volume":"210","author":"EM Bijker","year":"2014","unstructured":"Bijker, E. M. et al. Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites. J. Infect. Dis. 210, 1605\u20131615 (2014).","journal-title":"J. Infect. Dis."},{"key":"555_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.12688\/wellcomeopenres.11864.1","volume":"2","author":"EM Pasini","year":"2017","unstructured":"Pasini, E. M. et al. An improved Plasmodium cynomolgi genome assembly reveals an unexpected methyltransferase gene expansion. Wellcome Open Res. 2, 42 (2017).","journal-title":"Wellcome Open Res."},{"key":"555_CR9","unstructured":"Coatney, G. R. & National Institute of Allergy and Infectious Diseases (U.S.). The primate malarias. (U.S. National Institute of Allergy and Infectious Diseases; for sale by the Supt. of Docs., U.S. Govt. Print. Off., Washington, 1971)."},{"key":"555_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-68","volume":"13","author":"TH Ta","year":"2014","unstructured":"Ta, T. H. et al. First case of a naturally acquired human infection with Plasmodium cynomolgi. Malar. J. 13, 68 (2014).","journal-title":"Malar. J."},{"key":"555_CR11","doi-asserted-by":"publisher","unstructured":"Bykersma, A. The new zoonotic malaria: Plasmodium cynomolgi. Trop. Med. Infect. Dis. https:\/\/doi.org\/10.3390\/tropicalmed6020046 (2021).","DOI":"10.3390\/tropicalmed6020046"},{"key":"555_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejphar.2015.03.023","volume":"759","author":"Hart t","year":"2015","unstructured":"t, Hart et al. The translational value of non-human primates in preclinical research on infection and immunopathology. Eur. J. Pharmacol. 759, 69\u201383 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"555_CR13","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.4049\/jimmunol.179.6.4193","volume":"179","author":"P Bejon","year":"2007","unstructured":"Bejon, P. et al. The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. J. Immunol. 179, 4193\u20134201 (2007).","journal-title":"J. Immunol."},{"key":"555_CR14","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/S0140-6736(11)60360-7","volume":"377","author":"M Roestenberg","year":"2011","unstructured":"Roestenberg, M. et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377, 1770\u20131776 (2011).","journal-title":"Lancet"},{"key":"555_CR15","doi-asserted-by":"publisher","first-page":"e1009594","DOI":"10.1371\/journal.ppat.1009594","volume":"17","author":"SC Murphy","year":"2021","unstructured":"Murphy, S. C. et al. PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: a randomized, placebo-controlled trial with controlled human malaria infection. PLoS Pathog. 17, e1009594 (2021).","journal-title":"PLoS Pathog."},{"key":"555_CR16","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1128\/AAC.02576-13","volume":"58","author":"D Saunders","year":"2014","unstructured":"Saunders, D. et al. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta). Antimicrob. Agents Chemother. 58, 7283\u20137291 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"555_CR17","first-page":"302","volume":"23","author":"RN Prasad","year":"1985","unstructured":"Prasad, R. N., Garg, S. K., Mahajan, R. C. & Ganguly, N. K. Chloroquine kinetics in normal and P. knowlesi infected rhesus monkeys. Int. J. Clin. Pharm. Ther. Toxicol. 23, 302\u2013304 (1985).","journal-title":"Int. J. Clin. Pharm. Ther. Toxicol."},{"key":"555_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4269\/ajtmh.2011.09-0759","volume":"84","author":"A Jordan-Villegas","year":"2011","unstructured":"Jordan-Villegas, A. et al. Immune responses and protection of Aotus monkeys immunized with irradiated Plasmodium vivax sporozoites. Am. J. Trop. Med. Hyg. 84, 43\u201350 (2011).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"555_CR19","doi-asserted-by":"publisher","first-page":"e45861","DOI":"10.1371\/journal.pone.0045861","volume":"7","author":"W Wijayalath","year":"2012","unstructured":"Wijayalath, W. et al. Strain-specific protective effect of the immunity induced by live malarial sporozoites under chloroquine cover. PLoS ONE 7, e45861 (2012).","journal-title":"PLoS ONE"},{"key":"555_CR20","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41591-018-0117-4","volume":"24","author":"C Junqueira","year":"2018","unstructured":"Junqueira, C. et al. Cytotoxic CD8(+) T cells recognize and kill Plasmodium vivax-infected reticulocytes. Nat. Med. 24, 1330\u20131336 (2018).","journal-title":"Nat. Med"},{"key":"555_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22740-w","volume":"12","author":"Z Sulyok","year":"2021","unstructured":"Sulyok, Z. et al. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial. Nat. Commun. 12, 2518 (2021).","journal-title":"Nat. Commun."},{"key":"555_CR22","doi-asserted-by":"crossref","unstructured":"Mendes, A. M. A Plasmodium berghei sporozoite-based vaccination platform against human malaria. npj Vaccines 3, 33 (2018).","DOI":"10.1038\/s41541-018-0068-2"},{"key":"555_CR23","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.1006662107","volume":"107","author":"X Li","year":"2010","unstructured":"Li, X. et al. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant. Proc. Natl Acad. Sci. USA 107, 13010\u201313015 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"555_CR24","doi-asserted-by":"publisher","first-page":"e54888","DOI":"10.1371\/journal.pone.0054888","volume":"8","author":"A Voorberg-van der Wel","year":"2013","unstructured":"Voorberg-van der Wel, A. et al. Transgenic fluorescent Plasmodium cynomolgi liver stages enable live imaging and purification of Malaria hypnozoite-forms. PLoS ONE 8, e54888 (2013).","journal-title":"PLoS ONE"},{"key":"555_CR25","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1016\/j.vaccine.2015.09.095","volume":"33","author":"EM Bijker","year":"2015","unstructured":"Bijker, E. M. et al. Novel approaches to whole sporozoite vaccination against malaria. Vaccine 33, 7462\u20137468 (2015).","journal-title":"Vaccine"},{"key":"555_CR26","doi-asserted-by":"publisher","unstructured":"Blight, J. et al. Dissection-independent production of Plasmodium sporozoites from whole mosquitoes. Life Sci. Alliance https:\/\/doi.org\/10.26508\/lsa.202101094 (2021).","DOI":"10.26508\/lsa.202101094"},{"key":"555_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.1211548","volume":"334","author":"JE Epstein","year":"2011","unstructured":"Epstein, J. E. et al. Live attenuated malaria vaccine designed to protect through hepatic CD8(+) T cell immunity. Science 334, 475\u2013480 (2011).","journal-title":"Science"},{"key":"555_CR28","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1128\/AAC.01927-13","volume":"58","author":"AM Zeeman","year":"2014","unstructured":"Zeeman, A. M. et al. KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro. Antimicrob. Agents Chemother. 58, 1586\u20131595 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"555_CR29","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1128\/IAI.01267-12","volume":"81","author":"BW Faber","year":"2013","unstructured":"Faber, B. W. et al. Diversity covering AMA1-MSP119 fusion proteins as malaria vaccines. Infect. Immun. 81, 1479\u20131490 (2013).","journal-title":"Infect. Immun."},{"key":"555_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-32","volume":"12","author":"KA Kusi","year":"2012","unstructured":"Kusi, K. A. et al. Measurement of the plasma levels of antibodies against the polymorphic vaccine candidate apical membrane antigen 1 in a malaria-exposed population. BMC Infect. Dis. 12, 32 (2012).","journal-title":"BMC Infect. Dis."},{"key":"555_CR31","doi-asserted-by":"publisher","first-page":"6143","DOI":"10.1016\/j.vaccine.2008.08.055","volume":"26","author":"BW Faber","year":"2008","unstructured":"Faber, B. W. et al. Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris. Vaccine 26, 6143\u20136150 (2008).","journal-title":"Vaccine"},{"key":"555_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1006\/jmbi.1999.2753","volume":"289","author":"WD Morgan","year":"1999","unstructured":"Morgan, W. D. et al. Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1. J. Mol. Biol. 289, 113\u2013122 (1999).","journal-title":"J. Mol. Biol."},{"key":"555_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/BF00932618","volume":"80","author":"M Tsuji","year":"1994","unstructured":"Tsuji, M., Mattei, D., Nussenzweig, R. S., Eichinger, D. & Zavala, F. Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol. Res. 80, 16\u201321 (1994).","journal-title":"Parasitol. Res."},{"key":"555_CR34","doi-asserted-by":"publisher","unstructured":"Boszormenyi, K. et al. A bacterially-expressed recombinant envelope protein from usutu virus induces neutralizing antibodies in rabbits. Vaccines (Basel) https:\/\/doi.org\/10.3390\/vaccines9020157 (2021).","DOI":"10.3390\/vaccines9020157"},{"key":"555_CR35","first-page":"297","volume":"49","author":"JA Deans","year":"1982","unstructured":"Deans, J. A. et al. Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin. Exp. Immunol. 49, 297\u2013309 (1982).","journal-title":"Clin. Exp. Immunol."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-022-00555-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-022-00555-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-022-00555-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T18:28:07Z","timestamp":1666895287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-022-00555-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["555"],"URL":"https:\/\/doi.org\/10.1038\/s41541-022-00555-0","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"8 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}